SEOVF (Sernova Biotherapeutics) Notes Receivable: $0.00 Mil (As of Apr. 2026)


SEOVF Sernova Biotherapeutics Inc SEOVF
30 GF Score
Price $0.10
! 2 Warning Signs
View Full Analysis

What is Sernova Biotherapeutics Notes Receivable?

Sernova Biotherapeutics SEOVF +3.70% 30 Notes Receivable is $0.00 Mil as of Apr. 2026. GuruFocus rates SEOVF with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

Sernova Biotherapeutics's Notes Receivable for the quarter that ended in Apr. 2026 was $0.00 Mil.

Sernova Biotherapeutics Notes Receivable Related Terms

Sernova Biotherapeutics Notes Receivable Historical Data

* Premium members only.

The historical data trend for Sernova Biotherapeutics's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sernova Biotherapeutics Notes Receivable Chart

Sernova Biotherapeutics Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sernova Biotherapeutics Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SEOVF
30GF Score
Sernova Biotherapeutics Inc SEOVF
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sernova Biotherapeutics Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Sernova Biotherapeutics (SEOVF) has a Notes Receivable of $0.00 Mil as of Apr. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Sernova Biotherapeutics and its competitors.
Is Sernova Biotherapeutics' Notes Receivable too high?
Sernova Biotherapeutics' current Notes Receivable is $0.00 Mil. Overall, Sernova Biotherapeutics has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Sernova Biotherapeutics' Notes Receivable compare to VRTX and REGN?
Sernova Biotherapeutics' Notes Receivable of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Sernova Biotherapeutics and its competitors. Sernova Biotherapeutics's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sernova Biotherapeutics stock overvalued right now?
Sernova Biotherapeutics (SEOVF) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Sernova Biotherapeutics' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Sernova Biotherapeutics (SEOVF), the current Notes Receivable is $0.00 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sernova Biotherapeutics Business Description

Other Exchanges PSH0:GermanySVA:Canada
Address RPO Central Parkway, PO Box 29592, Mississauga, ON, CAN, L5A 4H2
Sernova Biotherapeutics Inc is a clinical-stage biotechnology company focused on advancing regenerative medicine for the treatment of chronic diseases. The Company's primary asset is its proprietary Cell Pouch, a bio-hybrid organ system designed to enhance the delivery of cell therapy by replicating natural body functions. The Cell Pouch creates a vascularized, organ-like environment that promotes the longevity and functionality of therapeutic cells and ensures containment for retrievability.
30GF Score

Get the complete analysis for SEOVF

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price